Treatment of Fibromyalgia, Myofascial Pain, and Related Disorders

Physical Medicine and Rehabilitation Clinics of North America

Volumn 17, Issue 2, 2006, Pages 491-510

  Borg Stein, Joanne ^a  

^a Rehabilitation Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BOTULINUM TOXIN A; CLONIDINE; CYCLOBENZAPRINE; DOPAMINE; DULOXETINE; GABAPENTIN; MILNACIPRAN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREGABALIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TRAMADOL; VENLAFAXINE;

ACETYLCHOLINE RELEASE; ACUPUNCTURE; BEHAVIOR THERAPY; CHRONIC PAIN; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG UPTAKE; ELECTROENCEPHALOGRAM; EXERCISE; FEEDBACK SYSTEM; FIBROMYALGIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEADACHE; HUMAN; INTRACTABLE PAIN; ISCHIALGIA; LABORATORY TEST; MASSAGE; MUSCLE CELL; MUSCULOSKELETAL PAIN; MYALGIA; MYOFASCIAL PAIN; NERVE ENDING; NOCICEPTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL MEDICINE; PARESTHESIA; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; REVIEW; STRESS; TENSION HEADACHE; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; TRIGGER POINT; ULTRASOUND; VISUAL ANALOG SCALE;

ADULT; ANALGESICS; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; FACIAL NEURALGIA; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT EDUCATION; PHYSICAL THERAPY MODALITIES; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33645996407     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2005.12.003     Document Type: Review

References (102)

1. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 criteria for classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172
2. Borg-Stein J., and Simons D.G. Myofascial pain. Arch Phys Med Rehabil 83 Suppl 1 (2002) S40-S47
3. Goldenberg D.L. Office management of fibromyalgia. Rheum Dis Clin North Am 28 2 (2002) 437-446
4. Gran J.T. The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17 4 (2003) 547-561
5. Buskila D., Neumann L., and Press J. Genetic factors in neuromuscular pain. CNS Spectr 10 4 (2005) 281-284
6. Skootsky S.A., Jaeger B., and Oye R.K. Prevalence of myofascial pain in general internal medicine practice. West J Med 151 (1989) 157-160
7. Gerwin R.D. A study of 96 subjects examined both for fibromyalgia and myofascial pain. J Musculoskeletal Pain 3 Suppl 1 (1995) 121
8. Kaergaard A., and Anderson J.H. Musculoskeletal disorders of the neck and shoulders in female sewing machine operators: prevalence, incidence, and prognosis. Occup Environ Med 57 (2000) 528-534
9. Borg-Stein J., and Yunus M. Myofascial and soft tissue causes of low pain. In: Cole A.J., and Herring S.A. (Eds). The low back pain handbook (2003), Hanley & Belfus, Philadelphia 453-467
10. Fields H.L. Pain (1987), McGraw-Hill, New York p. 210
11. Simons D.G., Travell J.G., and Simons L.S. Myofascial pain and dysfunction: the trigger point manual, Vol. 1. Upper half of body. 2nd edition (1999), Williams & Wilkins, Baltimore
12. Fricton J.R., Kroening R., Haley D., et al. Myofascial pain syndrome of the head and neck: a review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Path 60 (1985) 615-623
13. Kraybak B., Borg-Stein J., Oas J., et al. Reduced dizziness and pain with treatment of cervical myofascial pain. [abstract]. Arch Phys Med Rehabil 77 (1996) 939-940
14. Dohrenwend B.P., Raphael K.G., Marbach J.J., et al. Why is depression comorbid with chronic myofascial face pain? A family study test of alternative hypotheses. Pain 83 (1999) 183-192
15. Gallagher R.M., and Verma S. Managing pain and comorbid depression: a public health challenge. Semin Clin Neuropsychiatry 4 (1999) 203-220
16. Schwartz R.A., Greene C.S., and Laskin D.M. Personality characteristics of patients with myofascial pain - dysfunction syndrome unresponsive to conventional therapy. J Dent Res 58 (1979) 1435-1439
17. Henriksson K.G. Hypersensitivity in muscle pain syndromes. Curr Pain Headache Rep 7 6 (2003) 426-432
18. Mense S., Simons D.G., and Russell I.J. Muscle pain: understanding its nature, diagnosis, and treatment (2001), Lippincott, Williams & Wilkins, Philadelphia
19. Yunus M.B. Fibromyalgia and myofascial pain syndrome: clinical features, laboratory tests, diagnosis and pathophysiologic mechanisms. In: Rachlin E.S. (Ed). Myofascial pain and fibromyalgia (1994), Mosby, St. Louis 3-29
20. Yunus M.B., Kalyan-Raman U.P., Masi A.T., et al. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 16 (1989) 97-101
21. Yunus M.B., and Masi A.T. Fibromyalgia, restless legs syndrome, periodic limb movement disorder and psychogenic pain. In: McCarty Jr. D.J., and Koopman W.J. (Eds). Arthritis and allied conditions: a textbook of rheumatology (1992), Lea & Febiger, Philadelphia 1383-1405
22. Mense S. Pathophysiologic basis of muscle pain syndromes. Phys Med Rehabil Clin N Am 8 (1997) 179-196
23. Simons D.G., Hong C.Z., and Simons L.S. End plate potentials are common to midfiber myofascial trigger points. Am J Phys Med Rehabil 81 (2002) 212-222
24. Couppe C., Midttun A., Hilden J., et al. Spontaneous needle electromyographic activity in myofascial trigger points in the infraspinatus muscle: a blinded assessment. J Musculoskeletal Pain 9 (2001) 7-17
25. Liley A.W. An investigation of spontaneous activity in the neuromuscular junction of the rat. J Physiol 132 (1956) 650-666
26. Heuser J., and Miledi R. Effect of lanthanum ions on function and structure of frog neuromuscular junctions. Proc R Soc Lond Biol Sci 179 (1971) 247-260
27. Simons D.G., and Stolov W.C. Microscopic features and transient contraction of palpable bands in canine muscle. Am J Phys Med 55 (1976) 65-88
28. Reitinger A., Radner H., et al. [Morphologic studies of trigger points.]. Manuelle Med 34 (1996) 256-262 [in German]
29. Shah J.P., Phillips T.M., Danoff J.V., et al. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol 99 5 (2005) 1977-1984
30. Heheisel U., Mense S., Simons D.G., et al. Appearance of new receptive fields in rat dorsal horn neurons following noxious stimulation of skeletal muscle: a model for referral of muscle pain?. Neurosci Lett 153 (1993) 9-12
31. Vecchiet L., Vecchiet J., and Giamberardino M.A. Referred muscle pain: clinical and pathophysiologic aspects. Curr Rev Pain 3 (1999) 489-498
32. Bahr R., Blumberg H., and Janig W. Do dichotomizing afferent fibers exist which supply visceral organs as well as somatic structures? A contribution to the problem of referred pain. Neurosci Lett 24 (1981) 25-28
33. Davidoff R.A. Trigger points and myofascial pain: toward understanding how they affect headaches. Cephalalgia 18 (1998) 436-448
34. Baraniuk J.N., Whalen G., Cunningham J., et al. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 5 1 (2004) 48
35. Russell I.F., Littman B., Orr M.D., et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37 (1994) 1593-1601
36. Russell I.F., Michalek J.E., Vipraio G.A., et al. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19 (1992) 104-109
37. Moldofsy H., England R., Scarisbrick P., et al. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis" syndrome and healthy subjects. Psychosom Med 37 (1975) 341-351
38. Bennett R.M., Cook D.M., Clark S.R., et al. Hypothalamic-pituitary-insulin like growth factor-1 axis dysfunction in patients with fibromyalgia. J Rheumatol 24 (1997) 1384-1389
39. Ahles T.A., Khan S.A., Yunus M.G., et al. Psychiatric status of fibromyalgia and rheumatoid arthritis patients and nonpain controls: a blinded comparison of DSM-III diagnoses. Am J Psychiatry 148 (1991) 1721-1726
40. Cook D.B., Lange G., Ciccone D.S., et al. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 31 2 (2004) 364-378
41. Gracely R.H., Petzke F., Wolf J.M., et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46 5 (2002) 1333-1343
42. Goldenberg D.L., Felson D.T., and Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29 (1986) 1371-1377
43. Russell I.J., Fletcher E.M., Michalek J.E., et al. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo controlled study. Arthritis Rheum 34 (1991) 552-560
44. Fossaluzza V., and DeVita S. Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. Int J Clin Pharmacol Res 12 (1992) 99-102
45. Wolfe F., Zhao S., and Lane N. Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 43 (2000) 378-385
46. Wilder-Smith C.H., Hill L., Spargo K., et al. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAIDs: a randomized study comparing analgesia, antinociception and gastrointestinal effects. Pain 91 (2001) 23-31
47. Roth S.H. Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 25 (1998) 1358-1363
48. Katz W.A. Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs 52 Suppl 3 (1996) 39-47
49. Biasi G., Manca S., Manganelli S., et al. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 18 1 (1998) 13-19
50. Schnitzer R.J., Gray W.L., Paster R.Z., et al. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 27 (2000) 772-778
51. Goldenberg D., Mayskiy M., Mossey C., et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 39 (1996) 1852-1859
52. Bendtsen L., and Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 20 (2000) 603-610
53. Brown Jr. B.R., and Womble J. Cyclobenzaprine in intractable pain syndromes with muscle spasm. JAMA 240 (1978) 1151-1152
54. O'Malley P.G., Balden E., Tomkins G., et al. Treatment of fibromyalgia with antidepressant: a meta-analysis. J Gen Intern Med 15 (2000) 659-666
55. Bennett R. Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Curr Opin Rheumatol 10 (1998) 95-103
56. Sayar K., Aksu G., Ak I., et al. Venlafaxine treatment of fibromyalgia. Ann Pharmacother 37 11 (2003) 1561-1565
57. Arnold L.M., Lu Y., Crofford L.J., et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50 9 (2004) 2974-2984
58. Offenbaecher M., and Ackenheil M. Current trends in neuropathic pain treatments with special reference to fibromyalgia. CNS Spectr 10 4 (2005) 285-297
59. Davies J. Selective depression of synaptic transmission of spinal neurons in the cat by a new centrally acting muscle relaxant, 5-chloro-4-(2-imidazolin-2-yl-amino)-2, 1, 3-bensothiodazole (DS 103-282). Br J Pharmacol 76 (1982) 473-481
60. Ono H., Mishima A., Ono S., et al. Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by alpha-adrenergic receptor antagonists. Neuropharmacology 30 (1991) 585-589
61. Crofford L.J., Rowbotham M.C., Mease P.J., et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 4 (2005) 1264-1273
62. Fragoso Y.D., and Carrazana E.J. Low doses of gabapentin may be helpful in the management of chronic daily headache. Med Gen Med 2 3 (2000) E52
63. Smith H.S., Audette J., and Royal M.A. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain 18 6 Suppl (2002) S147-S154
64. Dodick DW, Mauskop A, Elkind AH, et al, BOTOX CDH. Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications. A randomized double-blind, placebo-controlled study. Headache 2005;45(4):315-24.
65. Troost B.T. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches. Expert Rev Neurother 4 1 (2004) 27-31
66. Cheshire W.P., Abashian S.W., and Mann J.D. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59 (1994) 65-69
67. Fishman L.M., Konnoth C., and Rozner B. Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study. Am J Phys Med Rehabil 83 1 (2004) 42-50
68. Fishman L.M., Anderson C., and Rosner B. BOTOX and physical therapy in the treatment of piriformis syndrome. Am J Phys Med Rehabil 81 12 (2002) 936-942
69. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85 (2000) 101-105
70. Wheeler A.H., Goolkasian P., and Gretz S.S. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 23 (1998) 1662-1666
71. Gobel H., Heinze A., Henize-Kuhn K., et al. [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes.]. Nervenarzt 72 (2001) 261-274 [in German]
72. Aoki K.R. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26 5 (2005) 785-793
73. Komiyama O., Kawara M., Arai M., et al. Posture correction as part of behavioural therapy in treatment of myofascial pain with limited opening. J Oral Rehabil 26 (1999) 428-435
74. Edwards R.H. Hypotheses of peripheral and central mechanisms underlying occupational muscle pain and injury. Eur J Appl Physiol Occup Physiol 57 (1988) 275-281
75. Bhatnager V., Drury C.G., and Schiro S.G. Posture, postural discomfort, and performance. Hum Factors 57 (1985) 189-199
76. Crockett D.J., Foreman M.E., Alden L., et al. A comparison of treatment modes in the management of myofascial pain dysfunction syndrome. Biofeedback Self Regul 11 (1986) 279-291
77. Ferraccioli G., Ghirelli L., Scita F., et al. EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 14 (1987) 820-825
78. Kaplan K.H., Goldenberg D.L., and Galvin-Nadeau M. The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry 15 (1993) 284-289
79. Berman B.M., Ezza J., Hadhazy V., et al. Is acupuncture effective in the treatment of fibromyalgia?. J Fam Pract 48 (1999) 213-218
80. Assefi N.P., Sherman K.J., Jacobsen C., et al. A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia. Ann Intern Med 143 1 (2005) 10-19
81. Acupuncture. NIH Consensus statement 15 5 (1997) 1-34
82. Birch S., and Jamison R.H. Controlled trial of Japanese acupuncture for chronic myofascial neck pain: assessment of specific and nonspecific effects of treatment. Clin J Pain 14 (1998) 248-255
83. Melzack R., Stillwell D.M., and Fox E.J. Trigger points and acupuncture points for pain: correlations and implications. Pain 3 (1977) 3-23
84. Gam A.N., Warming S., Larsen L.H., et al. Treatment of myofascial trigger points with ultrasound combined with massage and exercise: a randomized controlled trial. Pain 77 (1998) 73-79
85. Hernandez-Reif M., Field T., Krasnegor J., et al. Lower back pain is reduced and range of motion increased after massage therapy. Int J Neurosci 106 (2001) 131-145
86. Kruger L.R., Van der Linden W.J., and Cleaton-Jones P.E. Transcutaneous electrical nerve stimulation in the treatment of myofascial pain dysfunction. S Afr J Surg 36 (1998) 35-38
87. Graff-Radford S.B., Reeves J.L., Baker R.L., et al. Effects of transcutaneous electrical nerve stimulation in the treatment of myofascial pain and trigger point sensitivity. Pain 37 (1989) 1-5
88. Mannerkorpi K. Exercise in fibromyalgia. Curr Opin Rheumatol 17 2 (2005) 190-194
89. Graff-Radford S.B., Reeves J.L., and Jaeger B. Management of chronic headache and neck pain: effectiveness of altering factors perpetuating myofascial pain. Headache 27 (1987) 186-190
90. Feinberg B.I., and Feinberg R.A. Persistent pain after total knee arthroplasty: treatment with manual therapy and trigger point injections. J Musculoskeletal Pain 6 (1998) 85-95
91. Travell J.G., and Simons D.G. Myofascial pain and dysfunction: the trigger point manual (1983), Williams & Wilkins, Baltimore
92. Hong C.Z. Lidocaine injection versus dry needling to myofascial trigger point: the importance of the local twitch response. Am J Phys Med Rehabil 73 (1994) 256-263
93. Childers M.K., and Simons D.G. Botulinum toxin use in myofascial pain syndromes. In: Lennard T.A. (Ed). Pain procedures in clinical practice. 2nd edition (2000), Hanley & Belfus, Philadelphia 191-202
94. Cummings T.M., and White A.R. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil 82 (2001) 986-992
95. Baldry P.E., Yunus M.B., and Inanici F. Myofascial pain and fibromyalgia syndromes: a clinical guide to diagnosis and management (2001), Churchill Livingstone, Edinburgh
96. Chu J. Twitch-obtaining intramuscular stimulation: observations in the management of radiculopathic chronic low back pain. J Musculoskeletal Pain 7 (1999) 131-146
97. Gunn C.C. The Gunn approach to the treatment of chronic pain: intramuscular stimulation for myofascial pain of radiculopathic origin. 2nd edition (1996), Churchill Livingston, New York
98. Fischer A.A., and Imamura M. New concepts in the diagnosis and management of musculoskeletal pain. In: Lennard T.A. (Ed). Pain procedures in clinical practice. 2nd edition (2000), Hanley & Belfus, Philadelphia 213-229
99. Cassisi J.E., Sypert G.W., Lagana L., et al. Pain, disability, and psychological functioning in chronic low back pain subgroups: myofascial versus herniated disk syndrome. Neurosurgery 33 (1993) 379-385 [discussion: 385-6]
100. Roth R.S., Horowitz K., and Bachman J.E. Chronic myofascial pain: knowledge of diagnosis and satisfaction with treatment. Arch Phys Med Rehabil 79 (1998) 966-970
101. Heikkila H., Heikkila E., and Eisemann M. Predictive factors for the outcome of a multidisciplinary pain rehabilitation programme on sick-leave and life satisfaction in patients with whiplash trauma and other myofascial pain: a follow-up study. Clin Rehabil 12 (1998) 487-496
102. Wolfe F., Anderson J., Harkness D., et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40 9 (1997) 1571-1579